Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

3 Undervalued, Oversold Healthcare Companies Ready to Ride Sector's Uptrend Higher

Published 09/26/2024, 05:09 PM
MCK
-
HUM
-
HAE
-
XLV
-

The healthcare sector (NYSE:XLV) is often considered a defensive market; however, its diversity in services and products makes it less homogeneous compared to sectors like finance or public services.

In today's analysis, we focus on various healthcare companies, each with distinct business profiles.

What unites them is the common thread of being oversold, as indicated by the RSI oscillator, alongside a suggested growth potential of at least 20% based on the InvestingPro fair value indicator.

Additionally, the technical indicators suggest a possible reversal based on the developing pattern and tested support levels.

1. Humana: Growth Potential Ahead of the Presidential Election

Humana (NYSE:HUM) is a health insurance company operating in the U.S. market, which, unlike Europe, has a lower availability of insurance.

It is estimated that in the U.S., aside from public support, about 60% of adult citizens currently use private insurance, indicating further potential for expansion in this area.

The upcoming presidential election is crucial, where a victory for Kamala Harris could theoretically benefit insurance companies.

However, this remains highly uncertain, especially after the recent presidential debate, which lacked specific details regarding health policy.

Fundamentally, Humana boasts a relatively high fair value ratio, which is the highest among the companies analyzed.

Humana's Fair Value Index

Source: InvestingPro

From a technical standpoint, in addition to the oversold condition, attention should be drawn to the critical support level at $300. This is where this year's lows are forming, which could again become a turning point for buyers.

2. McKesson Corporation: Navigating a 5-Wave Elliott Wave Pattern

McKesson Corporation (NYSE:MCK) has a broad range of operations in supplements and medical products.

Like Humana, McKesson's fair value index indicates over 28% potential growth, with the stock currently in a local downtrend, correcting a broader uptrend.

The focus is primarily on the structure of the movement in the southern direction, within which a 5-wave Elliott wave pattern is being formed.

Technical Analysis of McKesson Corporation

A potential level to watch is the currently tested support of $465, where we see demand reactions, or slightly lower at the frequently tested level of $440.

The main signal for a return to growth would be a breakout above the forming price channel and an attempt to target $530.

3. Haemonetics Corporation: Financial Stability and Strong Performance

Haemonetics Corporation (NYSE:HAE) stands out as the most specialized company in this list, primarily engaged in devices for plasma and blood collection.

Its main advantages include a very good financial situation, confirmed by InvestingPro’s financial health indicator.

Haemonetics Corporation's Financial Health Index

Source: InvestingPro

The financial stability of Haemonetics is further highlighted by its net profits over the past two years, which have shown significant stabilization compared to pre-2022 period.

Haemonetics Corporation's Net Profits

After experiencing stock price declines in late July and August, the company’s shares entered a consolidation phase within the $71 to $79 per share range. It is worth monitoring this area, as a breakout above could signal a compelling buying opportunity.

***

Disclaimer: This article is written for informational purposes only. It is not intended to encourage the purchase of assets in any way, nor does it constitute a solicitation, offer, recommendation or suggestion to invest. I would like to remind you that all assets are evaluated from multiple perspectives and are highly risky, so any investment decision and the associated risk is at the investor's own risk. We also do not provide any investment advisory services. We will never contact you to offer investment or advisory services.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.